Usefulness of serum C-reactive protein levels in early prediction of chemoradiation response for advanced esophageal cancer

Biotherapy

Volumn 23, Issue 2, 2009, Pages 113-118

  Fujiwara, Hitoshi ^a   Suchi, Kentaro ^a   Okamura, Shinichi ^a   Okamura, Hiroko ^a   Umehara, Seiji ^a   Todo, Momoko ^a   Kubota, Takeshi ^a   Ichikawa, Daisuke ^a   Kikuchi, Shojiro ^a   Okamoto, Kazuma ^a   Otsuji, Eigo ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Chemoradiation therapy; Early prediction; Esophageal squamous carcinoma; Responder; Serum CRP

Indexed keywords

C REACTIVE PROTEIN; CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; PREOPERATIVE TREATMENT; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

EID: 64849109188     PISSN: 09142223     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Shimada, H., Nabeya, Y., Okazumi, S., et al.: Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J. Surg. Oncol. 83:248-252. 2003.
2. Guillem, P. and Triboulet. J.P.: Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis. Esophagus. 18:146-150, 2005.
3. Crumley, A.B.C., McMillan, D.C., McKernan, M., et al.: An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer- specific survival in patients undergoing resection for gastro-oesophageal cancer. Br. J. Cancer 94:1568-1571, 2006.
4. Shimada, H., Kitabayashi. H., Nabeya, Y., et al.: Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery 133:24-31, 2003.
5. Nozoe, T., Saeki, H. and Sugimachi, K.: Significance of preoperative elevation of serum C- reactive protein as an indicator of prognosis in esophageal carcinoma. Am. J. Surg. 182:197-201, 2001.
6. Japanese source
7. Leu, CM., Wong. F.H., Chang, C. et al.: Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways. Oncogene 22:7809- 7818, 2003.
8. Ueno, H., Okada, S., Okusaka, T., et al.: Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology 59:296-301, 2000.
9. Heys, S.D., Ogston, K.N., Simpson. W.G., et al.: Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival. Int. J. Oncol. 13:589-594, 1998.
10. Maccio, A., Lai, P., Santona, M.C., et al.: High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer. Gynecol. Oncol. 69:248-252. 1998.